Bayer and Nuvisan Create Research Unit in Berlin

  • Author:
  • Published: 11 February 2020
  • Copyright: Wiley-VCH Verlag GmbH & Co. KGaA
  • Source / Publisher: Bayer AG
  • Associated Suppliers: Bayer AG, Leverkusen, Germany
thumbnail image: Bayer and Nuvisan Create Research Unit in Berlin

Bayer will transfer a large part of its small molecule research unit based in Berlin, Germany, to Nuvisan, an international service provider for clinical studies, laboratory services, and contract manufacturing.

The Berlin-based research unit with around 400 workplaces comprises of a fully operational team specialized in small molecule research. Bayer will retain significant research activities in Berlin which remains the headquarters for the company’s Pharmaceuticals Division and one of its major global research sites.

The partnership will lay the foundation for a new research entity that will be established by Nuvisan in Berlin. The transaction is expected to close mid of 2020 subject to the successful completion of the consultation process with the employee representatives and the preparations for taking over the research activities.





Article Views: 926

Sign in Area

Please sign in below

Additional Sign In options

Please note that to comment on an article you must be registered and logged in.
Registration is for free, you may already be registered to receive, e.g., the newsletter. When you register on this website, please ensure you view our terms and conditions. All comments are subject to moderation.

Article Comments - To add a comment please sign in

Bookmark and Share

If you would like to reuse any content, in print or online, from, please contact us first for permission. more

CONNECT: on Facebook on Twitter on YouTube on LinkedIn Sign up for our free newsletter

Magazine of Chemistry Europe (16 European Chemical Societies)published by Wiley-VCH